Valeant Pharmaceuticals International Inc. April 12 announced that it has acquired Pedinol Pharmacal Inc., a podiatry-focused specialty pharmaceutical company based in Farmingdale, N.Y.
Pendinol’s revenue for 2011 was approximately $18 million, Montreal-based Valeant said. Further details were not disclosed.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.